Brief: Rockwell Medical Reports Completion of Patient Enrollment in Pivotal Trial of Triferic in China
25/04/2022 13:13
April 25 (Reuters) - Rockwell Medical Inc RMTI.O :
* ROCKWELL MEDICAL ANNOUNCES COMPLETION OF PATIENT
ENROLLMENT
AHEAD OF SCHEDULE IN PIVOTAL PHASE 3 CLINICAL TRIAL OF TRIFERIC®
IN CHINA
* ROCKWELL MEDICAL INC - LOOK FORWARD TO COMPLETION OF TRIAL
IN
2023
Source text for Eikon: ID:nPn65Mffsa
Further company coverage: RMTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rockwell Medical
See all newsRockwell Medical Inc reports results for the quarter ended June 30 - Earnings Summary
Rockwell Medical Q2 sales rise 11% on new customers
Rockwell Medical Inc expected to post a loss of 23 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:30 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM